Yi-Qun Han (Yiqun Han)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Metastatic Breast Cancer

Squamous Cell Carcinoma

Prognostic Factors

Clinical Practice

Top Venues

Journal of personalized medicine

Cancer medicine

Cancer control : journal of the Moffitt Cancer Center

This page only lists publications with an associated author ORCID identifier.

Publications

Zhijun Li, Yi-Qun Han, Jiayu Wang, Binghe Xu
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Yi-Qun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe Xu
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal transduction and targeted therapy 8 (1) (2023)
Zhijun Li, Yi-Qun Han, Jiayu Wang, Binghe Xu
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy. Journal of personalized medicine 13 (2) (2023)
Hangcheng Xu, Yi-Qun Han, Yun Wu, Yan Wang, Jiayu Wang, Bing-He Xu
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysis. Cancer medicine (2022)
Jiani Wang, Yi-Qun Han, Jiayu Wang, Qing Li, Binghe Xu
Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis. Cancers 14 (24) (2022)
Yi-Qun Han, Jiayu Wang, Zijing Wang, Binghe Xu
Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis. Cancer control : journal of the Moffitt Cancer Center 28 (2022)
Jiani Wang, Yi-Qun Han, Jiayu Wang, Qing Li, Binghe Xu
Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis. Cancers 14 (24) (2022)
Yan Wang, Hangcheng Xu, Yi-Qun Han, Yun Wu, Jiayu Wang
Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis. Cancers 14 (14) (2022)
Fengzhu Guo, Zongbi Yi, Wenna Wang, Yi-Qun Han, Pei Yu, Su Zhang, Quchang Ouyang, Min Yan, Xiaojia Wang, Xichun Hu, Zefei Jiang, Tao Huang, Zhongsheng Tong, Shu-Sen Wang, Yongmei Yin, Hui Li, Runxiang Yang, Huawei Yang, Yuee Teng, Tao Sun, Li Cai, Hongyuan Li, Xi Chen, Jianjun He, Xinlan Liu, Shune Yang, Jinhu Fan, You Lin Qiao, Jiayu Wang, Bing-He Xu
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter study. Cancer medicine 10 (19) (2021)
Yi-Qun Han, Jia-Yu Wang, Bing-He Xu
Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer. BioMed research international 2021 (2021)
Yi-Qun Han, Zong-Bi Yi, Pei Yu, Wen-Na Wang, Qu-Chang Ouyang, Min Yan, Xiao-Jia Wang, Xi-Chun Hu, Ze-Fei Jiang, Tao Huang, Zhong-Sheng Tong, Shu-Sen Wang, Yong-Mei Yin, Hui Li, Run-Xiang Yang, Hua-Wei Yang, Yue-E Teng, Tao Sun, Li Cai, Hong-Yuan Li, Xue-Nong Ouyang, Jian-Jun He, Xin-Lan Liu, Shun-E Yang, You-Lin Qiao, Jin-Hu Fan, Jia-Yu Wang, Bing-He Xu
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China. Journal of oncology 2021 (2021)